Extended-release versus oral buprenorphine as opioid maintenance treatment during pregnancy-maternal and neonatal outcomes

CONCLUSIONS: Extended-release buprenorphine with steady drug concentration seems to be a promising pharmacotherapy option during pregnancy for mothers. Maternal health during pregnancy may contribute to the well-being of newborns. Larger trials are urgently needed to confirm these results..PMID:38608352 | DOI:10.1016/j.ejogrb.2024.04.003

Source: Reproductive Biology - April 12, 2024 Category: Reproduction Medicine Authors: Minna Kanervo Sarimari Tupola Eeva Nikkola Krista Rantakari Hanna Kahila Source Type: research